Fluence Corporation Ltd
F:4SVE
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.004
0.0795
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Fluence Corporation Ltd
Fluence Corp. Ltd. engages in the provision of water treatment solutions. The firm's segments include Operating Units (OUs) and Product and Innovation Group (P&I). Its smart products solutions include Aspiral, NIROBOX and SUBRE. Aspiral is a smart wastewater treatment solution that packages the Company's membrane aerated biofilm reactor technology in standard shipping containers. NIROBOX is a small-footprint, containerized solutions to treat water from any source at any scale. SUBRE upgrades wastewater plants using membrane aerated biofilm reactor modules. Its aerated equipment includes TORNADO Surface Aspirating Aerator, HURRICANE Submersible Aerator, RIPTIDE Direct-Drive Surface Mixer, BREEZE Air Stripper, CYCLONE Coarse Bubble Diffuser, MONSOON Horizontal Surface Aerator and others. The firm primarily focuses on markets including China, the Middle East, Southeast Asia, and North America.
Fluence Corp. Ltd. engages in the provision of water treatment solutions. The firm's segments include Operating Units (OUs) and Product and Innovation Group (P&I). Its smart products solutions include Aspiral, NIROBOX and SUBRE. Aspiral is a smart wastewater treatment solution that packages the Company's membrane aerated biofilm reactor technology in standard shipping containers. NIROBOX is a small-footprint, containerized solutions to treat water from any source at any scale. SUBRE upgrades wastewater plants using membrane aerated biofilm reactor modules. Its aerated equipment includes TORNADO Surface Aspirating Aerator, HURRICANE Submersible Aerator, RIPTIDE Direct-Drive Surface Mixer, BREEZE Air Stripper, CYCLONE Coarse Bubble Diffuser, MONSOON Horizontal Surface Aerator and others. The firm primarily focuses on markets including China, the Middle East, Southeast Asia, and North America.
Revenue Growth: Fiscal 2025 revenue was $78.4 million, up 52% from fiscal 2024, with Q4 2025 revenue of $26.0 million, an increase of 22% over Q4 2024.
Profitability Achieved: EBITDA reached $4.0 million for the year, a turnaround from the prior year’s $4.0 million loss, hitting the midpoint of guidance.
Margin Expansion: Gross margin held steady at 29.9% despite a higher contribution from lower-margin projects, with strong improvements across core business units.
Record Orders: Q4 2025 saw $24.5 million in new orders, Fluence’s largest quarter on record for its core product lines.
Strong Backlog: Fiscal year-end backlog was just under $75 million, with $53 million expected to convert to revenue in fiscal 2026.
Positive Cash Flow: Operating cash flow was $10.9 million for the year, and the company ended with $16.6 million in cash.
2026 Outlook: Management expects double-digit revenue growth and further gross margin expansion in 2026, even as contributions from the Ivory Coast Addendum project decrease.
Legacy Write-Downs: A $4.5 million reserve was taken for overdue Egyptian receivables, which management believes is likely the last major write-down.
